After calculating a creatinine clearance, providers should consider calculating an actual GFR as well, to determine the staging/severity of a patient's chronic kidney disease.
|CKD stage||GFR level (mL/min/1.73 m2)|
|Stage 1||≥ 90|
|Stage 2||60 – 89|
|Stage 3||30 – 59|
|Stage 4||15 – 29|
|Stage 5||< 15|
Cockcroft-Gault CrCl = (140-age) * (Wt in kg) * (0.85 if female) / (72 * Cr)
Ideal Body Weight (IBW), Men (Devine) = 50 + (2.3 * (Height in inches - 60) )
Ideal Body Weight (IBW), Women (Devine) = 45.5 + (2.3 * (Height in inches - 60) )
Adjusted Body Weight (ABW) = IBW + 0.4 * (TBW - IBW) where 0.4 is a correction factor, and TBW is total (actual) body weight
Facts & Figures
The most common formula for determining creatinine clearance, which estimates Glomerular Filtration Rate (GFR); creatinine clearance may over-estimate GFR by 10-20%, but still remains the standard for drug dosing adjustments.
Based on several papers and expert opinions, we now provide adjustments to the Cockcroft-Gault equation based on body weight and BMI, as it appears to become less accurate in weight extremes (underweight and particularly overweight/obesity). As recommended by Brown et. al and Winter et. al, we provide adjustments and estimates as follows:
Original/Primary ReferenceCockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41. PubMed PMID: 1244564.
Other ReferencesWinter MA, Guhr KN, Berg GM. Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation. Pharmacotherapy. 2012 Jul;32(7):604-12. doi:10.1002/j.1875-9114.2012.01098.x. Epub 2012 May 10. PubMed PMID: 22576791.Brown DL, Masselink AJ, Lalla CD. Functional range of creatinine clearance for renal drug dosing: a practical solution to the controversy of which weight to use in the Cockcroft-Gault equation. Ann Pharmacother. 2013 Jul-Aug;47(7-8):1039-44. doi: 10.1345/aph.1S176. Epub 2013 Jun 11. Review. PubMed PMID: 23757387.
About the Creator
Donald W. Cockcroft, MD, is a professor of medicine at the University of Saskatchewan. He is co-chair of Airways Research Group and the chair of the Quality Assurance Committee. Dr. Cockcroft specializes in asthma practice and research.
To view Dr. Donald Cockcroft's publications, visit PubMed
About the Creator
Henry Gault, MD, MSc, (d. 2003) was named professor emeritus in 1993 after nearly 20 years as a physician and professor at Memorial University of Newfoundland. He was also director for the Division of Nephrology at the General Hospital and of the Renal Laboratory. Dr. Gault was a pioneer in the field of nephrology and his work on urine enzymology was a major influence on the discovery of the diagnosis of the rejection of kidney transplants.
To view Dr. Henry Gault's publications, visit PubMed